LIMA1 and hepatocellular carcinoma: To investigate the effects of LIMA1 on HCC progression, we transfected an overexpression plasmid into YY8103 and HCCLM3 cell lines with relatively lower LIMA1 levels and depleted the LIMA1 in the Huh7 cell line with relatively higher LIMA1 levels using a targeted shRNA (Supplementary Figure S1A,B).